Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Primary Care
Published in: BMC Primary Care 1/2017

Open Access 01-12-2017 | Research article

Moderate mental illness as a predictor of chronic disease prevention and screening

Authors: Ginetta Salvalaggio, Christopher Meaney, Rahim Moineddin, Eva Grunfeld, Donna Manca

Published in: BMC Primary Care | Issue 1/2017

Login to get access

Abstract

Background

Primary care plays a pivotal role in the provision of both mental health care and chronic disease prevention and screening (CDPS). Unfortunately, moderate mental illness (MMI) is associated with poorer general health outcomes. Part of this burden of illness may be due to reduced CDPS uptake. The Building on the Existing Tools to Improve Chronic Disease Prevention in Primary Care (BETTER) trial recruited 777 participants ages 40–65 from 32 family practice panels, of whom 135 (18.2%) had elevated GAD scores, 118 (16.4%) had elevated PHQ scores, and 264 (34.0%) had electronic medical record (EMR)-documented MMI. We hypothesized that patients with screen-positive or chart-documented MMI are 1) eligible for more CDPS actions, and 2) able to complete a lower proportion of CDPS actions than patients unaffected by MMI.

Methods

This study was a secondary analysis of data from the BETTER trial. Participants were stratified by both EMR-documented MMI and screen-positive evidence of MMI (using the General Anxiety Disorders (GAD-7) and Patient Health Questionnaire (PHQ-9) instruments for anxiety and depression screening, respectively). The primary outcome was the proportion of CDPS actions for which the patient was eligible completed at follow-up, using a composite index.

Results

After adjusting for age, gender, and social support, patients with evidence of MMI had a lower composite index than patients without evidence of MMI (p < 0.05). The lower composite index is primarily due to higher eligibility for CDPS at baseline; ability to complete CDPS was not statistically different.

Conclusions

Patients affected by MMI are eligible for more CDPS actions than their unaffected counterparts. Although they are able to complete a similar number of CDPS actions, they are not able to eliminate their baseline CDPS gap. Primary care teams need to be aware of this increased CDPS eligibility for patients with MMI and ensure best practices in CDPS supports are available to this patient population. Further study is needed to determine the ideal suite of targeted supports.
Literature
1.
World Health Organization., World Organisation of National Colleges Academies and Academic Associations of General Practitioners/Family Physicians. Integrating mental health into primary care: a global perspective. Geneva, Switzerland, London: World Health Organization; Wonca; 2008.
2.
Craven MA, Bland R. Depression in primary care: current and future challenges. Can J Psychiatry. 2013;58(8):442–8.CrossRefPubMed
3.
4.
Williams JW Jr, Rost K, Dietrich AJ, Ciotti MC, Zyzanski SJ, Cornell J. Primary care physicians' approach to depressive disorders. Effects of physician specialty and practice structure. Arch Fam Med. 1999;8(1):58–67.CrossRefPubMed
5.
Houle J, Beaulieu MD, Lesperance F, Frasure-Smith N, Lambert J. Inequities in Medical Follow-Up for Depression: A Population-Based Study in Montreal. Psychiatr Serv. 2010;61(3):258–63.CrossRefPubMed
6.
Ostbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005;3(3):209–14.CrossRefPubMedPubMedCentral
7.
8.
Linzer M, Bitton A, Tu SP, Plews-Ogan M, Horowitz KR, Schwartz MD. Association of C, Leaders in General Internal Medicine Writing G, Poplau S, Paranjape A et al: The End of the 15-20 Minute Primary Care Visit. J Gen Intern Med. 2015;30(11):1584–6.
9.
Raffoul M, Moore M, Kamerow D, Bazemore A. A Primary Care Panel Size of 2500 Is neither Accurate nor Reasonable. J Am Board Fam Med. 2016;29(4):496–9.CrossRefPubMed
10.
Health FPaTACoP. Toward a healthy future: second report on the health of Canadians. Ottawa, ON: Minister of Public Works and Government Services Canada; 1999.
11.
Allen J, Balfour R, Bell R, Marmot M. Social determinants of mental health. Int Rev Psychiatry. 2014;26(4):392–407.CrossRefPubMed
12.
13.
Zgibor JC, Songer TJ. External Barriers to Diabetes Care: Addressing Personal and Health Systems Issues. Diabetes Spectrum. 2001;14(1):23–8.CrossRef
14.
Burack RC. Barriers to clinical preventive medicine. Prim Care. 1989;16(1):245–50.PubMed
15.
Druss BG, Rosenheck RA, Desai MM, Perlin JB. Quality of preventive medical care for patients with mental disorders. Med Care. 2002;40(2):129–36.CrossRefPubMed
16.
Egede LE, Grubaugh AL, Ellis C. The effect of major depression on preventive care and quality of life among adults with diabetes. Gen Hosp Psychiatry. 2010;32(6):563–9.CrossRefPubMed
17.
Campbell-Scherer D, Rogers J, Manca D, Lang-Robertson K, Bell S, Salvalaggio G, et al. Guideline harmonization and implementation plan for the BETTER trial: Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Family Practice. CMAJ open. 2014;2(1):E1–E10.
18.
19.
Wong ST, Manca D, Barber D, Morkem R, Khan S, Kotecha J, et al. The diagnosis of depression and its treatment in Canadian primary care practices: an epidemiological study. CMAJ Open. 2014;2(4):E337–42.
20.
Grunfeld E, Manca D, Moineddin R, Thorpe KE, Hoch JS, Campbell-Scherer D, et al. Improving chronic disease prevention and screening in primary care: results of the BETTER pragmatic cluster randomized controlled trial. BMC Fam Pract. 2013;14(1):175.
21.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.CrossRefPubMed
22.
Herr NR, Williams JW Jr, Benjamin S, McDuffie J. Does this patient have generalized anxiety or panic disorder?: The rational clinical examination systematic review. JAMA. 2014;312(1):78–84.CrossRefPubMed
23.
Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ. 2012;184(3):E191–6.CrossRefPubMedPubMedCentral
24.
25.
Nietert PJ, Wessell AM, Jenkins RG, Feifer C, Nemeth LS, Ornstein SM. Using a summary measure for multiple quality indicators in primary care: the Summary QUality InDex (SQUID). Implement Sci. 2007;2:11.CrossRefPubMedPubMedCentral
26.
Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097–106.CrossRefPubMed
27.
Dierker LC, Avenevoli S, Stolar M, Merikangas KR. Smoking and depression: an examination of mechanisms of comorbidity. Am J Psychiatry. 2002;159(6):947–53.CrossRefPubMed
28.
Sullivan LE, Goulet JL, Justice AC, Fiellin DA. Alcohol consumption and depressive symptoms over time: A longitudinal study of patients with and without HIV infection. Drug Alcohol Depend. 2011;117(2–3):158–63.CrossRefPubMedPubMedCentral
29.
Fuehrlein BS, Mota N, Arias AJ, Trevisan LA, Kachadourian LK, Krystal JH, et al. The burden of alcohol use disorders in US military veterans: results from the National Health and Resilience in Veterans Study. Addiction. 2016;111(10):1786–94.
30.
Lawrence D, et al. Smoking, mental illness and socioeconomic disadvantage: analysis of the Australian National Survey of Mental Health and Wellbeing. BMC Public Health. 2013;13:462. doi:10.​1186/​1471-2458-13-462.
31.
Park AL, McDaid D, Weiser P, Von Gottberg C, Becker T, Kilian R, et al. Examining the cost effectiveness of interventions to promote the physical health of people with mental health problems: a systematic review. BMC Public Health. 2013;13:787.
Metadata
Title
Moderate mental illness as a predictor of chronic disease prevention and screening
Authors
Ginetta Salvalaggio
Christopher Meaney
Rahim Moineddin
Eva Grunfeld
Donna Manca
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2017
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/s12875-017-0645-x

Other articles of this Issue 1/2017

BMC Primary Care 1/2017 Go to the issue

Research article

An after hours gp clinic in regional Australia: appropriateness of presentations and impact on local emergency department presentations

Research article

‘Doing the right thing’: factors influencing GP prescribing of antidepressants and prescribed doses

Research article

Learning to use electronic health records: can we stay patient-centered? A pre-post intervention study with family medicine residents

Research article

From good health to illness with post-infectious fatigue syndrome: a qualitative study of adults’ experiences of the illness trajectory

Research article

Criteria in diagnosing nocturnal leg cramps: a systematic review

Research article

Musculoskeletal pain and co-morbid insomnia in adults; a population study of the prevalence and impact on restricted social participation